Abirapro 250 mg is a prescription medication used to treat certain types of prostate cancer. It is an oral tablet that contains abiraterone acetate, a selective inhibitor of the enzyme CYP17, which plays a key role in the production of androgens (male hormones).
COMPOSITION
Each tablet contains 250 mg of abiraterone acetate.
MECHANISM OF ACTION
Abiraterone works by inhibiting the production of androgens, which can help slow down the growth of prostate cancer cells. By reducing the levels of androgens, such as testosterone, abiraterone can help shrink or stabilize tumors in some patients.
USES
Abirapro 250 mg is used to treat:
- Metastatic castration-resistant prostate cancer (mCRPC) in patients who have received prior chemotherapy containing platinum compounds
- Locally advanced high-risk prostate cancer in patients who are at high risk of developing mCRPC
DOSAGE
The recommended dosage of Abirapro 250 mg is:
- 250 mg taken once daily with prednisone (10 mg) taken twice daily
- Take with food and a glass of water
SIDE EFFECTS
Common side effects of Abirapro 250 mg include:
- Fatigue
- Joint pain
- Muscle pain
- Hot flashes
- Nausea
- Vomiting
- Swelling
- High blood pressure
- Increased blood levels of potassium and sodium
RECOMMENDATION
Abirapro 250 mg should be used under the guidance of a healthcare professional. Patients should be monitored regularly for signs of side effects and potential liver toxicity.
IMPORTANT NOTE
Before starting Abirapro 250 mg, patients should discuss their medical history, including any kidney or liver problems, with their healthcare provider. Patients should also inform their healthcare provider if they have any other medications or supplements they are taking.
Reviews
There are no reviews yet.